biopharmaceutical industry Syndicate content

Mar 20, 2018

WUXI, China and BETHLEHEM, Pa., March 21, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, today announced that it has selected 4,000 liter (L) Custom Single Run (...